BSc Bioprocessing of New Medicines in Business and Management

UCL’s BSc in Bioprocessing of New Medicines (Business and Management) is an interdisciplinary programme that integrates scientific, engineering, and management perspectives to equip students with the knowledge and skills necessary for the development and commercialization of new medicines. The curriculum emphasizes hands-on learning experiences, including laboratory-based practicals, group projects, and exposure to real-world industry scenarios. Students engage in activities that foster critical thinking, problem-solving, and teamwork, preparing them for careers in the biopharmaceutical industry and related fields.

Experiential Learning Includes:

• Laboratory-Based Practicals: Students participate in laboratory sessions that provide practical experience in bioprocessing techniques, allowing them to apply theoretical knowledge to real-world scenarios.
• Group Projects: Collaborative projects enable students to work in teams, simulating industry environments and enhancing skills in communication, leadership, and project management.
• Industry Exposure: The programme offers opportunities for students to engage with industry professionals through guest lectures, seminars, and potential internships, providing insights into the biopharmaceutical sector.
• Business and Management Modules: Courses in business strategy, economics, and management equip students with the skills necessary to navigate the commercial aspects of the biopharmaceutical industry.
• Interdisciplinary Learning: Drawing on expertise from various disciplines, the programme fosters a holistic understanding of the bioprocessing field, integrating science, engineering, and business perspectives.
• Research Opportunities: Students have the chance to engage in research projects, contributing to advancements in bioprocessing and gaining experience in scientific inquiry.
• State-of-the-Art Facilities: UCL provides access to advanced laboratories and research facilities, supporting students in their practical learning and research endeavors.

This hands-on approach ensures that graduates are well-prepared for careers in biomedical research, healthcare, and related fields.

Graduates of UCL's Bioprocessing of New Medicines (Business and Management) BSc program typically pursue careers in bioprocessing, pharmaceutical management, and healthcare innovation. Common roles include Bioprocess Engineer, Pharmaceutical Project Manager, Healthcare Consultant, and Regulatory Affairs Specialist.

• Careers & Employment Support

  • The UCL Careers Service offers personalized support, including one-on-one consultations, CV workshops, interview preparation, and access to a wide range of employer events.
  • Students can engage in research projects within UCL's biomedical institutes, providing hands-on experience and networking opportunities.

• Employment Stats & Salary Figures

  • Approximately 90% of UCL Biomedical Sciences graduates are employed or pursuing further study within 15 months of graduation.
  • The median salary for graduates in related fields is around £32,500 15 months after completing their degree.

• University–Industry Partnerships

  • UCL's Translational Research Office facilitates over 130 industry collaborations, attracting more than £50 million in industry funding.
  • Students have opportunities to engage with leading biomedical companies and research institutions, enhancing their employability and exposure to cutting-edge developments.

• Accreditation & Long-Term Value

  • The BSc Bioprocessing of New Medicines program at UCL is not accredited by the Institute of Biomedical Science (IBMS), meaning it does not lead directly to HCPC registration as a Biomedical Scientist in the NHS. However, the program's strong research focus and UCL's global reputation provide graduates with valuable skills applicable across various sectors.

• Graduation Outcomes

  • Graduates are well-prepared for roles in research, healthcare, pharmaceuticals, and consultancy. Many also choose to pursue further studies, including MSc or PhD programs, leveraging UCL's extensive academic network and resources.

Further Academic Progression:
After completing the BSc Bioprocessing of New Medicines program, graduates have several pathways for further academic development:

• MSc Programs:

  • UCL offers a MSc in Biomedical Sciences, providing advanced knowledge and research opportunities in specialized areas.
  • Graduates can also consider MSc programs in related fields such as Pharmacology, Neuroscience, or Immunology at UCL or other leading institutions.

• PhD Opportunities:

  • With a strong research background, graduates are well-positioned to pursue PhD programs in biomedical sciences, contributing to innovative research and development in various biomedical fields.

• Graduate-Entry Medicine:

  • Some graduates opt for graduate-entry medical programs, utilizing their biomedical sciences background to transition into clinical practice.